: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Arsanis, Inc.(ASNS)$ EFFECT - Notice of Effectiveness Filed: 2017-11-15 AccNo: 9999999995-17-002979 Size: 1 KB 网页链接
$Arsanis, Inc.(ASNS)$ CERTNAS [Paper] - Certification by the National Association of Securities Dealers Automated Quotation approving securities for l Film#: 17010583 Filed: 2017-11-15 AccNo: 9999999997-17-009901 Size: 1 KB 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2017-11-20 AccNo: 0001193125-17-348213 Size: 180 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ EFFECT - Notice of Effectiveness Filed: 2017-11-15 AccNo: 9999999995-17-002979 Size: 1 KB 网页链接
$Arsanis, Inc.(ASNS)$ 424B1 - Prospectus [Rule 424(b)(1)] Filed: 2017-11-17 AccNo: 0001193125-17-345863 Size: 3 MB 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2017-11-20 AccNo: 0001193125-17-348213 Size: 180 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-16 AccNo: 0001193125-17-345721 Size: 78 KB 网页链接
$Arsanis, Inc.(ASNS)$ 424B1 - Prospectus [Rule 424(b)(1)] Filed: 2017-11-17 AccNo: 0001193125-17-345863 Size: 3 MB 网页链接
$Arsanis, Inc.(ASNS)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2017-11-15 AccNo: 0001193125-17-343803 Size: 3 MB 网页链接
$Arsanis, Inc.(ASNS)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-16 AccNo: 0001193125-17-345721 Size: 78 KB 网页链接